Literature DB >> 28502684

Metastatic Neuroendocrine Carcinoma of Unknown Origin Arising in the Femoral Nerve Sheath.

Nicholas Candy1, Adam Young1, Kieren Allinson2, Oliver Carr1, Jason McMillen1, Rikin Trivedi3.   

Abstract

BACKGROUND: Metastatic neuroendocrine carcinoma of unknown origin is a rare condition, usually presenting with lesions in the liver and/or lung. We present the first reported case of a metastatic neuroendocrine carcinoma of unknown origin arising in the femoral nerve sheath. CASE DESCRIPTION: Magnetic resonance imaging demonstrated what was thought to be a schwannoma in the left femoral nerve sheath in the proximal femoral triangle, immediately inferior to the anterior inferior iliac spine. At the time of operation, the tumor capsule was invading surrounding tissue, as well as three trunks of the femoral nerve. The patient underwent a subtotal resection, preserving the integrity of the residual functioning femoral nerve trunks. Histologic evaluation determined that the tumor had features consistent with a metastatic neuroendocrine carcinoma of unknown primary origin. The patient recovered well postoperatively, and subsequent radiologic evaluation failed to demonstrate a potential primary site. Unfortunately, the patient re-presented with disease progression and was subsequently referred to palliative care.
CONCLUSIONS: We recommend that there is a definite role for surgery in the management of solitary neuroendocrine carcinoma of unknown origin.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Carcinoma of unknown origin; Neuroendocrine carcinoma; Peripheral nerve sheath tumor

Mesh:

Substances:

Year:  2017        PMID: 28502684     DOI: 10.1016/j.wneu.2017.05.013

Source DB:  PubMed          Journal:  World Neurosurg        ISSN: 1878-8750            Impact factor:   2.104


  1 in total

Review 1.  An abdominal wall neuroendocrine tumor of unknown primary origin: A case report and review of the literature.

Authors:  Olivia Jagiella-Lodise; Valerie Jagiella; Evan Weitman
Journal:  Cancer Rep (Hoboken)       Date:  2022-02-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.